What it is
AlphaProteo is DeepMind's generative system for designing protein binders that latch onto a specified target with high affinity, often working from just the target structure. It aims to accelerate the creation of research tools and therapeutic leads.
Evidence trail
BioAtlas keeps the path from source to decision visible. A connection records provenance; it does not imply that evidence is sufficient for every context.
Model passport
How AlphaProteo represents biology
Category is navigation. These fields describe the model-specific computational transformation and deliberately override broad category defaults.
Biological scale
Modalities & tasks
Registry, claims and frontier intelligence
Version history not yet curated
1 version record · release year not yet normalized. Model-family identity remains separate from capability and access changes.
Explore version lineage →0 normalized claims
No task, dataset, split and metric claim has been normalized for this record yet.
Open claim intelligence →2 connected frontiers
Protein programming · Peer-reviewed capability
Inspect research horizon →Connected research frontiers
These records describe active research directions, not guaranteed capabilities of this model. Evidence stages and unresolved questions are preserved separately.
Multimodal protein programming
EvolutionaryScale · 2025-01-16Can one generative model reason jointly over protein sequence, structure and function and create functional proteins from mixed prompts?
Evidence boundary and unresolved questions
One striking protein demonstration does not establish general success across enzymes, therapeutics or complex multi-objective design tasks.
- How frequently do generated functions survive experimental testing?
- Can the model optimize potency, stability and safety together?
- How should synthetic training labels affect confidence?
multimodal · protein language model · function generation · synthetic biologyOpen frontier record →Prospective de novo binder generation
Google DeepMind · 2024-09-05Can AI generate high-affinity protein binders for diverse targets with fewer rounds of experimental optimization?
Evidence boundary and unresolved questions
Performance varies by target; the system did not succeed on every attempted target and is not publicly released for unrestricted reproduction.
- Which target properties predict designability?
- How transferable are success rates to membrane and flexible targets?
- Can developability, immunogenicity and function be optimized jointly?
protein binders · prospective validation · generative design · wet labOpen frontier record →Inputs and outputs
Inputs
Target structure or design objectiveOutputs
Designed sequencesCandidate structuresScientific and technical profile
Scientific principles
Technology
Scientific lineage
These are transparent concept matches—not claims that one scientist alone caused this model. Each connection is based on the model’s recorded domain, scientific principles, technical terms or an explicit lineage link.
Anfinsen’s dogma—the thermodynamic hypothesis
Christian B. AnfinsenProtein structure prediction, inverse folding and generative protein design all assume that sequence strongly constrains structure and function.
Atomic structures of biologically important molecules by X-ray crystallography
Dorothy Crowfoot HodgkinStructure-based drug design depends on the experimental structural tradition she helped establish.
The alpha helix, beta sheet and hydrogen-bonded protein structure
Linus Pauling, Robert Corey & Herman BransonProtein representation, fold recognition, structural priors and generative protein design all encode these recurring geometric motifs.
The central dogma and directional information transfer
Francis CrickMulti-omic models and sequence foundation models connect genotype, transcript and protein through this information-flow framework.
Levinthal’s paradox and efficient folding pathways
Cyrus LevinthalModern folding algorithms, energy landscapes, learned priors and diffusion models solve a constrained search problem rather than brute-force conformational enumeration.
Phage display and selection of binding proteins
George P. Smith & Sir Gregory P. WinterDisplay-based selection created an experimental search engine for protein binders and remains a core validation partner for computational antibody design.
Evaluation evidence
BioAtlas has not yet extracted a structured benchmark claim for this record.
Known limitations
- Independent reproducibility is limited by proprietary access.
- A structured benchmark claim has not yet been extracted for this record.
- Outputs require task-specific scientific and experimental validation.
Milestones
Reported strong binding across diverse target proteins.
Complements AlphaFold in the design → validate loop.